Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Cilostazol Versus Aspirin for Secondary Prevention of Vascular Events After Stroke of Arterial Origin." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435757/0/. Accessed 02 May 2024.
Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435757/0/. Accessed May 2, 2024.
Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/435757/0/
Cilostazol Versus Aspirin for Secondary Prevention of Vascular Events After Stroke of Arterial Origin [Internet]. In: Cochrane Abstracts. [cited 2024 May 02]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435757/0/.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Cilostazol versus aspirin for secondary prevention of vascular events after stroke of arterial origin
ID - 435757
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435757/0/
DB - Evidence Central
DP - Unbound Medicine
ER -